English | Español
Danielle Pacey | Nov 14, 2018

Study examines inhaled insulin for treating Type 1 diabetes
Press release submission | Nov 7, 2018

PROMIS NEUROSCIENCES, INC: Discusses Critical Importance of Selectively Targeting the Root Cause of Alzheimer’s Disease
Press release submission | Nov 7, 2018

PARTNER THERAPEUTICS: Receives FDA Orphan Drug Designation for Leukine® for the Treatment of Pulmonary Alveolar Proteinosis
Press release submission | Nov 4, 2018

ALKERMES: Reports on Outcome of FDA Advisory Committee Meeting on ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder
Press release submission | Nov 4, 2018

U.S. FOOD AND DRUG ADMINISTRATION: FDA permits marketing of two devices that detect parathyroid tissue in real-time during surgery
Press release submission | Oct 26, 2018

ABBVIE: To Assume Full Development and Commercial Control of Cystic Fibrosis Research Program
Press release submission | Oct 26, 2018

ABBOTT: Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
Karen Kidd | Oct 23, 2018

Think tank founder recommends standard patents over intellectual property rights to cut drug prices

Trending
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Mark Cuban on PBMs: ‘Patients are getting ripped off because PBMs and wholesalers insist on using inflated list prices'
Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'
+ Pharmaceuticals
Patient Daily | Nov 3, 2025

Patient groups urge Congress to renew enhanced premium tax credits before open enrollment
Patient Daily | Nov 5, 2025

Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’